Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Immune checkpoint and angiogenic inhibitors for the treatment of hepatocellular carcinoma: It takes two to tangle
Caecilia Sukowati; Loraine Kay D. Cabral; Claudio Tiribelli;
Ann Hepatol. 2022;27:
Clinical treatment of cholangiocarcinoma: an updated comprehensive review
Alessandra Elvevi; Alice Laffusa; Miki Scaravaglio; Roberta Elisa Rossi; Raffaella Longarini; Anna Maria Stagno; Laura Cristoferi; Antonio Ciaccio; Diego Luigi Cortinovis; Pietro Invernizzi; Sara Massironi;
Ann Hepatol. 2022;27:
Effect of pembrolizumab on viral hepatitis load and transaminases in advanced hepatocellular carcinoma
Stephen Lam Chan; Richard S. Finn; Julien Edeline; Sadahisa Ogasawara; Jennifer J. Knox; Bruno Daniele; Baek-Yeol Ryoo; Philippe Merle; Mohamed Bouattour; Ho-Yeong Lim; Yee Chao; Thomas Yau; Barbara Anne Haber; Usha Malhotra; Abby B. Siegel; Chih-Chin Liu; Masatoshi Kudo; Ann-Lii Cheng;
10.1016/j.aohep.2025.102169